Advertisement
Coronavirus China
ChinaScience

BA.2.75.2: the new Omicron strain showing a worrying ability to evade immunity

  • The strain has two mutations that make it even more adept at locking on to human cells
  • Researchers in China say it has an unprecedented growth advantage

Reading Time:2 minutes
Why you can trust SCMP
24
A new Omicron strain shows a striking ability to evade existing antibody treatment, scientists say. Photo: National Institute of Allergy and Infectious Diseases/AFP
Zhuang Pinghui

Scientists have identified a new strain of the Omicron coronavirus variant that, according to laboratory studies, is the most adept at dodging immunity.

The new strain, BA.2.75.2, is a sublineage of the BA.2.75 variant, which was initially reported in India in May and gained attention for its growth advantage.

The variant did not take off in a world dominated by BA.5.
Advertisement

But now the new BA.2.75.2 strain is looming as a bigger threat with two mutations that make it even more likely to bind to human cells for infection, according to researchers.

Worse still, the strain shows a strong ability to evade immunity from vaccination and previous infection, possibly making antibody treatments less effective.

01:40

Highly contagious new Omicron subvariant BA.2.75 latest global Covid challenge

Highly contagious new Omicron subvariant BA.2.75 latest global Covid challenge

A group of researchers from Imperial College London, the Karolinska Institutet and the University of Cape Town identified “extensive escape” by BA.2.75.2. On average, it is 6½ times more difficult to neutralise, or block from infection, than BA.5, making it the most “neutralisation resistant variant” assessed to date, they said.

Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x